MitoCanada Research Profiles

Ground-breaking research that will prevent the devastating onset of mitochondrial disease and improve the lives of those already afflicted is urgently needed. Excellence in health research is a recognized strength in Canada. We are known globally for the rigour and success of our clinical trials. 

There is an urgent need to bring together the brightest minds across the globe to develop better solutions for supporting the MitoCommunity. MitoCanada is supporting incredible scientists. We invite you to get to know them, and their work.
 Dr. Jessika Royea

MitoCanada partners with MITO2i to fund mitochondrial research that could introduce new therapies for Alzheimer’s disease.

Read more...
 Dr. Colasanti

MitoCanada partners with the Lily Foundation and MITO2i to fund mitochondrial-specific mental health research

Read more...
 Dr. Khan

MitoCanada funds research to advance rapid diagnosis of mitochondrial disease.

Read more...
 Dr. Tarnopolsky

MitoCanada funds research to support the develop of novel therapies to treat mitochondrial diseases.

Read more...
 Dr. Tarnopolsky

MitoCanada funds research to support the develop of novel therapies to treat mitochondrial diseases.

Read more...
 Dr. Robert Screaton

MitoCanada is funding research to help introduce new breast cancer therapies that target mitochondrial metabolism vulnerabilities.

Read more...
Dr. Ingrid Tien

MitoCanada and Mito2i are collaboratively funding research exploring precision medicine to improve quality of life for those with autism spectrum disorder.

Read more...
Dr. Laura Rosella

MitoCanada and Mito2i are collaboratively funding research to explain the health system impact of mitochondrial disease and psychiatric conditions.

Read more...